πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8609838

Pyrimidine substituted purine derivatives

VERASTEM, INC. Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8609871

Process for production of optically active amine derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8604244

Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. Β· Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8598361

Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8592379

Metastin derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8592577

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8592464

Nitric oxide furoxan derivative compounds endowed with antitumoral activity

HUMANITAS MIRASOLE S.P.A. Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575185

Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

REVIVA PHARMACEUTICALS, INC. Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575119

2β€²-chloroacetylenyl substituted nucleoside derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563559

Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8562965

Polymer derivatives comprising an acetal or ketal branching point

Nektar Therapeutics Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563573

Azaindole derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8562949

Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546493

Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol

Nektar Therapeutics Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546612

Phenyl-N-acyl derivatives of amines and amino acids, a process for the preparation thereof

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œPHARMENTERPRISES” Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8541375

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8541457

Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536165

Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Almirall, S.A. Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536195

Bicyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8530489

5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase i

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524726

Amido derivatives and their use as positive allosteric modulators of metabotropic glutamat

Addex Pharma, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524718

Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic

Addex Pharma, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524910

Pyridyl derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8518957

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing in

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted